Navigation Links
Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update
Date:3/16/2009

  • Commercial Product Supply: In November, Poniard announced an agreement with Baxter Oncology GmbH for the commercial manufacture and supply of injectable picoplatin drug product. An agreement with W. C. Heraeus GmbH was established in March 2008 for the commercial manufacture of picoplatin active pharmaceutical ingredient.

  • Top 10 Oncology Product: In October, picoplatin was named by Windhover Information Inc., as one of the top 10 most promising oncology projects in development that is available for partnering.

Corporate Developments

  • Cash Position: The Company ended the year 2008 with cash and investment securities of $72.8 million. In September, Poniard drew down approximately $20 million of additional net cash proceeds under the Company's amended and restated loan facility with GE Healthcare Financial Services and Silicon Valley Bank.

  • New CFO: In February 2009, Greg Weaver was appointed Poniard's new chief financial officer and senior vice president. Mr. Weaver brings 17 years of experience in executive financial management to the Company, and has served as chief financial officer of public and private biotech and healthcare companies since 1996.

Fourth Quarter 2008 Financial Results

The Company reported a net loss of $13.9 million ($0.41 diluted loss per share on a loss applicable to common shares of $14.1 million) for the fourth quarter of 2008 compared with a net loss of $9.6 million ($0.28 diluted loss per share on a loss applicable to common shares of $9.7 million) for the fourth quarter of 2007. The Company reported a net loss of $48.6 million ($1.41 diluted loss per share on a loss applicable to common shares of
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
2. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
3. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
5. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
6. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
7. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
8. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
9. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
10. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
11. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... July 28, 2015 Codman Neuro*, part of ... a new platform of embolic coils for the treatment ... designed to improve microcatheter stability and provide an optimized ... made here at the Society of NeuroInterventional Surgery (SNIS) ... of framing, filling and finishing coils used during a ...
(Date:7/28/2015)... 28, 2015 Amgen (NASDAQ: AMGN ) ... $0.79 per share dividend for the third quarter of ... 2015, to all stockholders of record as of the ... About Amgen Amgen is committed to unlocking the ... by discovering, developing, manufacturing and delivering innovative human therapeutics. ...
(Date:7/28/2015)... 2015  Insulet Corporation (NASDAQ: PODD ), the ... ® Insulin Management System, today announced that Dr. ... Board of Directors. Dr. Hopfield brings more ... Insulet Board. She currently serves as the Vice Chair ... world,s largest diabetes research center, diabetes clinic, and provider ...
Breaking Medicine Technology:Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 2Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 3Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 4Amgen Announces 2015 Third Quarter Dividend 2Amgen Announces 2015 Third Quarter Dividend 3Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 2Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 3
... of Body Consistent with Overall PASI ... Response in REMICADE-Treated Patients, SAN ANTONIO, Feb. ... trials showed patients with moderate,to severe plaque psoriasis receiving REMICADE(R) ... of the four body regions,(head, trunk, lower and upper extremities) ...
... PRINCETON, N.J., Feb. 4 Pharmacopeia (Nasdaq:,PCOP), an ... small,molecule therapeutics, today announced that Dr. Leslie J. ... corporate presentation at the,BIO CEO & Investor Conference ... at The Waldorf-Astoria Hotel in New York City., ...
Cached Medicine Technology:REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 2REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 3REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 4REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 5REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 6REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 7REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 8REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 9REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 10Pharmacopeia to Present at BIO CEO & Investor Conference 2008 2Pharmacopeia to Present at BIO CEO & Investor Conference 2008 3
(Date:7/28/2015)... ... 2015 , ... Santa Rosa’s The Press Democrat announced its annual report of the very best ... Dr. Heather Furnas took the top spot as the Best Cosmetic Surgeons in Sonoma ... proud to be bestowed such a prestigious title. , The Press Democrat was ...
(Date:7/28/2015)... ... ... Mindful Her, a unique women’s wellness and lifestyle event designed to inspire and ... the next level, announced today an influential line-up of inspiring speakers, including Mallika Chopra, ... an Orange County based non-profit that works locally and globally to help girls become ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... the Lost and Found, a breakthrough technological invention. It is a wearable ... the consumer electronic industry reached a record high of $211.3 billion in 2014," ...
(Date:7/28/2015)... ... ... 2016, the number of smartphones worldwide will surpass 2 billion. This means that brands ... customer loyalty. However, capitalizing on this is not always obvious. Companies that do not, ... , The Open Mobile Summit 2015 is an influential gathering of mobile visionaries from ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... with 1 in 68 children currently affected with the disorder. For these families, ... the road to recovery is extremely daunting. That’s where Talk About Curing Autism ...
Breaking Medicine News(10 mins):Health News:Dr. Canales and Dr. Furnas Honored as Sonoma County’s Best Cosmetic Surgeons 2Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 2Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 3Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 2Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 3Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 4Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 5Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 2Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 3Health News:National TACA Autism Conference Offers Hope and Help to Families Affected by Autism 2
... cell research and manufacturing, announced today the appointment of Carl Bullen ... manufacturing systems and procedures at Stemedica,s San Diego-based manufacturing facility that ... , ... San Diego, CA (PRWEB) March 5, 2009 ...
... minimally-invasive (no-scalpel/no-stitch) hair transplant surgery benefits patients with better results, ... , ... Boca Raton, FL (PRWEB) ... available in the U.S. can dramatically improve hair transplant surgery ...
... CHARENTON-LE-PONT, France, March 5 , - 2008: Solid ... the Currency Effect, - Contribution Margin at 17.9%, ... Excluding the Currency, Effect), ... , The Board of Directors of Essilor ...
... Wake Forest University School of Medicine identifies the presence ... likely it is that elderly, hospitalized patients who receive ... heart attack. , An advance copy of the study ... Neurology , the official publication of the European Neurological ...
... is a statement by Matthew L. Myers, President, ... Energy and Commerce Committee today set Congress on ... reduce tobacco use by approving legislation granting the ... products. Today,s 39-13 vote underscores the broad, ...
... March 4 National Center for Creative Aging (NCCA) will ... programs as a way to engage people with dementia. The ... Symposium," will be held in Washington, D.C. on March ... said, "Cases of dementia and Alzheimer,s disease increase with age, ...
Cached Medicine News:Health News:Stemedica Announces the Appointment of Carl Bullen as Director of Manufacturing 2Health News:Stemedica Announces the Appointment of Carl Bullen as Director of Manufacturing 3Health News:New NeoGraft™ Device Improves Hair Transplants 2Health News:New NeoGraft™ Device Improves Hair Transplants 3Health News:Essilor : 2008 Results 2Health News:Essilor : 2008 Results 3Health News:Essilor : 2008 Results 4Health News:Essilor : 2008 Results 5Health News:Essilor : 2008 Results 6Health News:Essilor : 2008 Results 7Health News:Essilor : 2008 Results 8Health News:Essilor : 2008 Results 9Health News:Essilor : 2008 Results 10Health News:Essilor : 2008 Results 11Health News:Essilor : 2008 Results 12Health News:Essilor : 2008 Results 13Health News:Essilor : 2008 Results 14Health News:Essilor : 2008 Results 15Health News:Number of cardiovascular risk factors could determine safety of intravenous gammaglobulin treatment 2Health News:Number of cardiovascular risk factors could determine safety of intravenous gammaglobulin treatment 3Health News:House Committee Vote Sets Congress on Course for Historic Regulation of Tobacco Products 2Health News:House Committee Vote Sets Congress on Course for Historic Regulation of Tobacco Products 3Health News:National Center for Creative Aging Presents 'Creativity Matters' Symposium on Health, Wellness, and the Arts 2Health News:National Center for Creative Aging Presents 'Creativity Matters' Symposium on Health, Wellness, and the Arts 3Health News:National Center for Creative Aging Presents 'Creativity Matters' Symposium on Health, Wellness, and the Arts 4
Spectrafuge 16M High speed microcentrifuge. High g-force for molecular biology applications. Brushless, maintenance-free motor. Easy to use control panel. Complete with 18 x 1.5/2.0 ml rotor. StripSp...
... Powerful single rotation speed of 10,000 ... (x g) , Pellets single- and double-stranded ... and continuous spinning , 12-position rotor holds ... 1.5-ml microcentrifuge tubes , Replaceable rotor ...
... performance Model 5417 C spins up to 25,000 x ... unsurpassed safety, reliability, and ease of use. The Model ... bench or in a cold room and can accommodate ... Product features , Spin up to 16,400 ...
... and Proteomic users should inquire about ... Preparation capability for run-to-run replication. Compact ... accommodates 4x750 ml up to 4550xg ... throughput screening, research and patient specimen ...
Medicine Products: